Home
English
English
简体中文
Sign In
Help Desk
Journals
Advanced Search
BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
Featured Articles
Journals
Submit a Manuscript
Articles Published Processes
Keyword:
Direct-acting antivirals
Page 1 of 1 ( 49 items )
<<
1
>>
1
Chrono-optimal treatments for human immunodeficiency virus/hepatitis C virus co-infection yield comparable survival outcomes with hepatitis C virus mono-infection
1/16/2026 11:31:19 AM |
Browse: 146 |
Download: 630
2
Steatotic liver disease in patients with chronic hepatitis C
12/26/2025 10:27:32 AM |
Browse: 123 |
Download: 597
3
Thrombotic risk in hepatitis C: Interplay between hepatic dysfunction, viral-driven inflammation, and cardiovascular consequences
12/25/2025 9:13:55 AM |
Browse: 144 |
Download: 512
4
Direct-acting antiviral therapy reduces variceal rebleeding and improves liver function in hepatitis C virus-related cirrhosis: A multicenter retrospective cohort study
11/27/2025 7:53:58 AM |
Browse: 113 |
Download: 615
5
Sex-related differences in treatment outcomes of chronic hepatitis C with direct-acting antivirals
10/27/2025 10:57:49 AM |
Browse: 430 |
Download: 647
6
Hepatitis C virus-associated cardiomyopathy: A review of pathogenesis
9/25/2025 9:22:05 AM |
Browse: 356 |
Download: 713
7
Sex-related differences in patients with chronic hepatitis C infection treated with direct-acting antiviral drugs
6/26/2025 7:27:55 AM |
Browse: 352 |
Download: 924
8
Direct-acting antivirals failed to reduce the incidence of hepatocellular carcinoma occurrence in hepatitis C virus associated cirrhosis: A real-world study
1/23/2024 9:31:45 AM |
Browse: 469 |
Download: 1603
9
Real-world effectiveness and safety of direct-acting antivirals in hepatitis C virus patients with mental disorders
6/28/2023 7:41:04 AM |
Browse: 482 |
Download: 1920
10
Changes in characteristics of patients with hepatitis C virus-related cirrhosis from the beginning of the interferon-free era
4/7/2023 5:51:03 AM |
Browse: 648 |
Download: 1793
11
Glecaprevir/pibrentasvir + sofosbuvir for post-liver transplant recurrent hepatitis C virus treatment
2/24/2023 1:35:50 PM |
Browse: 645 |
Download: 1452
12
Best therapy for the easiest to treat hepatitis C virus genotype 1b-infected patients
12/2/2022 9:49:51 AM |
Browse: 739 |
Download: 1975
13
Hepatitis C virus burden: Treating and educating people without prejudice
7/27/2022 1:17:38 PM |
Browse: 826 |
Download: 2416
14
Fibrosis regression following hepatitis C antiviral therapy
6/23/2022 2:39:01 PM |
Browse: 854 |
Download: 2105
15
Impact of direct-acting antiviral regimens on hepatic and extrahepatic manifestations of hepatitis C virus infection
6/23/2022 2:39:01 PM |
Browse: 736 |
Download: 1549
16
Hepatocellular carcinoma, hepatitis C virus infection and miRNA involvement: Perspectives for new therapeutic approaches
6/10/2022 5:40:20 AM |
Browse: 875 |
Download: 2063
17
Outreach onsite treatment with a simplified pangenotypic direct-acting anti-viral regimen for hepatitis C virus micro-elimination in a prison
1/11/2022 8:34:26 AM |
Browse: 780 |
Download: 2425
18
Recently acquired hepatitis C virus infection among people living with human immunodeficiency virus at a university hospital in Taiwan
9/29/2021 11:12:00 AM |
Browse: 694 |
Download: 2272
19
Planning the hepatitis C virus elimination in Cyprus: A modeling study
8/18/2021 8:08:20 AM |
Browse: 786 |
Download: 2277
20
New hope for hepatitis C virus: Summary of global epidemiologic changes and novel innovations over 20 years
8/4/2021 7:56:20 AM |
Browse: 1126 |
Download: 2382
21
Towards a new era of hepatitis B virus therapeutics: The pursuit of functional cure
5/27/2021 9:41:33 AM |
Browse: 950 |
Download: 2156
22
Viral hepatitis: A brief introduction, review of management, advances and challenges
4/28/2021 12:31:49 PM |
Browse: 875 |
Download: 1707
23
Genotype 3-hepatitis C virus’ last line of defense
3/17/2021 6:19:34 AM |
Browse: 1002 |
Download: 2503
24
Facial and bilateral lower extremity edema due to drug-drug interactions in a patient with hepatitis C virus infection and benign prostate hypertrophy: A case report
8/6/2020 9:52:06 AM |
Browse: 1182 |
Download: 2700
25
Hepatocellular carcinoma in the post-hepatitis C virus era: Should we change the paradigm?
8/7/2019 7:09:17 AM |
Browse: 1373 |
Download: 2477
26
Leukocytoclastic vasculitis caused by hepatitis C virus in a liver transplant recipient: A case report
4/26/2019 3:40:00 AM |
Browse: 1521 |
Download: 2922
27
Spleen stiffness mirrors changes in portal hypertension after successful interferon-free therapy in chronic-hepatitis C virus patients
10/27/2018 4:40:10 AM |
Browse: 1538 |
Download: 3101
28
Challenge to overcome: Nonstructural protein 5A-P32 deletion in direct-acting antiviral-based therapy for hepatitis C virus
10/12/2018 5:32:21 AM |
Browse: 1026 |
Download: 1901
29
Metabolic syndrome does not affect sustained virologic response of direct-acting antivirals while hepatitis C clearance improves hemoglobin A1c
9/27/2018 9:38:46 AM |
Browse: 1532 |
Download: 2899
30
Fatty liver in hepatitis C patients post-sustained virological response with direct-acting antivirals
3/16/2018 12:27:25 PM |
Browse: 1716 |
Download: 3174
31
Efficacy of direct-acting antiviral treatment for chronic hepatitis C: A single hospital experience
1/26/2018 8:09:36 AM |
Browse: 1741 |
Download: 2985
32
Impact of sustained virologic response on chronic kidney disease progression in hepatitis C
12/27/2017 10:31:19 AM |
Browse: 1568 |
Download: 2911
33
Liver decompensation predicts ribavirin overexposure in hepatitis C virus patients treated with direct-acting antivirals
12/5/2017 1:55:00 AM |
Browse: 1495 |
Download: 2777
34
Efficacy and safety of sofosbuvir and daclatasvir in treatment of kidney transplantation recipients with hepatitis C virus infection
8/28/2017 6:54:48 AM |
Browse: 1689 |
Download: 3953
35
Risk of hepatitis B reactivation in patients treated with direct-acting antivirals for hepatitis C
6/26/2017 10:23:05 AM |
Browse: 1264 |
Download: 2357
36
Is it enough to eliminate hepatitis C virus to reverse the damage caused by the infection?
2/24/2017 9:02:00 AM |
Browse: 1313 |
Download: 2194
37
Treatment of chronic hepatitis C with direct-acting antivirals: The role of resistance
7/29/2016 8:32:00 PM |
Browse: 1550 |
Download: 2348
38
Hepatitis C virus genotypes in Myanmar
7/15/2016 3:38:00 PM |
Browse: 1362 |
Download: 2547
39
Antiviral therapy for hepatitis C: Has anything changed for pregnant/lactating women?
4/19/2016 2:32:00 PM |
Browse: 1710 |
Download: 2280
40
Update on hepatitis C: Direct-acting antivirals
12/4/2015 3:24:00 PM |
Browse: 1428 |
Download: 2536
41
Hepatitis C virus: A global view
11/18/2015 11:12:00 AM |
Browse: 1796 |
Download: 2642
42
Hepatitis C virus infection: Are there still specific problems with genotype 3?
11/11/2015 1:33:00 PM |
Browse: 1718 |
Download: 2882
43
Injecting drug use: A vector for the introduction of new hepatitis C virus genotypes
10/14/2015 12:06:00 PM |
Browse: 1490 |
Download: 2712
44
Psychosocial assessment and monitoring in the new era of non-interferon-alpha hepatitis C virus treatments
9/9/2015 2:44:00 PM |
Browse: 1574 |
Download: 2739
45
New treatment strategies for hepatitis C infection
8/21/2015 1:38:00 PM |
Browse: 1600 |
Download: 2637
46
Hepatitis C virus: Is it time to say goodbye yet? Perspectives and challenges for the next decade
4/19/2015 5:46:00 PM |
Browse: 1838 |
Download: 2327
47
Hepatitis C virus-specific cytotoxic T cell response restoration after treatment-induced hepatitis C virus control
3/30/2015 5:46:00 PM |
Browse: 1761 |
Download: 2805
48
Current status and emerging challenges in the treatment of hepatitis C virus genotypes 4 to 6
3/13/2015 3:29:00 PM |
Browse: 1719 |
Download: 2372
49
Hepatitis C virus in the new era: Perspectives in epidemiology, prevention, diagnostics and predictors of response to therapy
8/25/2014 2:47:00 PM |
Browse: 1543 |
Download: 1460
Page 1 of 1 ( 49 items )
<<
1
>>
Write to the Help Desk
Copyright © 1993-2026 Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA. All rights reserved, including rights relating to text and data mining, AI training, and similar technologies. For open-access content, the applicable copyright and licensing terms govern.